Clinical Trials

AstraZeneca's Imfinzi Nears EU Stomach Cancer Approval
Management & Regulatory AstraZeneca's Imfinzi Nears EU Stomach Cancer Approval

With deep expertise in biopharma innovation and oncology research and development, Ivan Kairatov offers a unique perspective on the latest breakthroughs in cancer treatment. Today, we delve into the recent positive opinion from European regulators for AstraZeneca’s Imfinzi in combination with

How Is Royal Openness Changing Public Health?
Research & Development How Is Royal Openness Changing Public Health?

The British monarchy, an institution historically defined by its stoic reserve, took an unprecedented step in 2024 when both King Charles and Catherine, the Princess of Wales, publicly disclosed their cancer diagnoses, shattering centuries of protocol that shrouded royal health in secrecy. This

Is a Single-Dose HIV Vaccine on the Horizon?
Research & Development Is a Single-Dose HIV Vaccine on the Horizon?

A groundbreaking study led by scientists at The Wistar Institute marks a significant leap forward in the decades-long search for an effective HIV vaccine, demonstrating that a novel vaccine candidate can induce neutralizing antibodies after just a single immunization in nonhuman primates. This

Should Cancer Treatment Be Gender-Specific?
Research & Development Should Cancer Treatment Be Gender-Specific?

For decades, the field of oncology has striven for precision, tailoring therapies to the unique genetic fingerprint of a tumor, yet a fundamental biological variable present in every cell of a patient's body has been largely overlooked: their sex. A groundbreaking study now challenges this

Portable Breast Ultrasound – Review
Research & Development Portable Breast Ultrasound – Review

The significant disparity in survival rates between early and late-stage breast cancer diagnoses has long propelled the search for more effective and frequent screening technologies beyond the established annual mammogram. The development of portable breast ultrasound represents a significant

Could This Mouse Make Antibody Drugs Safer?
Research & Development Could This Mouse Make Antibody Drugs Safer?

For decades, the path from a promising antibody discovery in the lab to a life-saving therapy for patients has been fraught with uncertainty. Many drugs that show incredible potential in early tests ultimately fail in human trials, costing billions and delaying medical progress. Today we're

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later